Rocket Lab's Launch Record Keeps Growing, but Neutron's Fourth-Quarter Deadline Is What Really Matters

Rocket Lab flew its 95th Electron mission and 16th of 2026, but shares sit 59% below their 52-week peak as investors await Neutron's Q4 pad move.

Rocket Lab closed out another Electron mission on Friday, sending an Earth-observation satellite into a circular orbit roughly 500 kilometers up for a client the company has not named. It marked the 16th Electron flight of 2026 and the 95th in the program's history — a cadence that has quietly turned small-launch operations into routine business for the Long Beach-based space firm.

Investors greeted the news with a modest 2.1% gain, lifting the shares to EUR 54.50. That single-session bump does little to alter a rougher stretch: over the past 30 days, the stock has shed 23%, leaving it far below its moving averages and 59% beneath its 52-week peak of EUR 133.80. The gap between what Rocket Lab keeps achieving on the pad and how the market prices its equity has become the defining tension of the story.

A launch log that keeps filling up

Friday's mission followed quickly on the heels of another milestone. On September 2, Rocket Lab flew its 94th Electron flight, carrying a StriX satellite for Japanese partner Synspective's SAR constellation. Yet another Electron launch is slated for later in September, underscoring how reliably the company now executes its core small-rocket business — an operational strength that tends to get lost when the share price is under pressure.

The company is not standing still on the technology side either. On September 9, it unveiled IMM Apex, a germanium-free solar cell for space applications that it says delivers an initial conversion efficiency of 31.5% while weighing 40% less than conventional multi-junction cells. The product reinforces Rocket Lab's ambition to be more than a launch provider — a vertically integrated supplier spanning the space value chain.

Neutron: the catalyst that carries the whole story

The bigger wager sits with Neutron, the company's new medium-lift rocket. When Rocket Lab reported second-quarter 2026 results on August 10, management confirmed that first-stage manufacturing remained on schedule and that Neutron would be moved to the launch pad in the fourth quarter of 2026. That timeline is the single most important catalyst on the horizon: hit it, and the growth narrative gets fresh fuel; slip again, and the market is unlikely to be forgiving.

The quarterly figures themselves captured a company in transition — USD 234.07 million in revenue against a loss of USD 0.08 per share. For a space firm still deep in its investment phase, that is hardly disastrous, but it also does not obviously justify a market capitalization of EUR 36.44 billion. The stock, in other words, is not being valued on what Rocket Lab is today but on what Neutron promises to make it.

Wall Street weighs in — with caveats

Raymond James initiated coverage on the same day as Friday's launch. Analyst Brian Gesuale assigned an Outperform rating and an USD 80 price target, describing Rocket Lab as a vertically integrated space platform with capabilities spanning launch vehicles, spacecraft, components, payloads, and optical communications. He sees Neutron, alongside the Iridium projects, opening additional offerings in the medium-lift segment and in applications and spectrum by 2027.

Gesuale did not shy away from the risks. He flagged that the gross margins the market appears to assume are ambitious, that moving Neutron from development into commercialization will demand substantial execution work, and that integration risk lingers from the Iridium and Mynaric acquisitions. His call lands as a snapshot of early-September sentiment rather than a verdict on the recent slide.

Berenberg had already stepped in a day earlier, on September 2, launching coverage with a Buy rating and an USD 83 price target — another vote of confidence in the long-term story at a moment when the shares were already softening.

Insider sales: routine, but worth a mention

Early in September, CFO Adam C. Spice exercised employee options on 140,157 shares at USD 1.09 and then sold the same number at weighted average prices of USD 62.26 and USD 62.97. The transaction was tied to an automated trading plan set up in June. Spice had also parted with just under 9,700 shares on August 24 to cover taxes on vesting RSUs.

COO Frank Klein sold roughly 35,500 shares on August 27, also through a trading plan established back in 2025. Such scheduled disposals are standard portfolio management for US executives rather than a red flag on the business — particularly since both men continue to hold substantial stakes. Still, the timing drew attention because it coincided with a period in which the stock was already losing ground.

Government contracts underpin the order book

Two large state contracts lend ballast to the operational base. In early August, Rocket Lab secured a USD 397 million award from the US Space Force for the SB-AMTI program, under which it will develop so-called Flatellites and launch them aboard the future Neutron rocket. That followed a multi-launch contract worth USD 266 million signed in late July, covering up to 18 suborbital flights.

For the third quarter of 2026, Rocket Lab projects revenue of USD 250 million to USD 265 million alongside an EBITDA-based operating loss of USD 17 million to USD 23 million. A growing backlog paired with persistent operating losses remains the central tension for shareholders, and with an RSI of 37.8, the technical picture leans toward oversold rather than overheated.

Where that leaves the stock

Strip away the noise and Rocket Lab looks like a company that is delivering operationally — steady launches, advancing technology, a tangible Neutron schedule — while its share price sits 22% below its 200-day moving average. On those measures, the setup points more toward stabilization than a continued slide, provided Neutron does indeed roll to the pad in the fourth quarter. Until then, the equity remains what it has been for months: a wager on a date, not on the present.